TARDBP and Alzheimer disease: Previous research has indicated that FDG-PET imaging in AD patients with co-existing TDP-43 proteinopathy reveals greater hypometabolism in specific brain regions, such as the medial temporal, frontal superior medial, and frontal supraorbital regions, when compared to AD patients without TDP-43 pathology [138,149].